---
title: "Bristol-Myers Squibb Co. v. Superior Court of California"
type: Landmark Case
source: https://casebriefly.com/landmark-cases/bristol-myers-squibb-v-superior-court
---

# Bristol-Myers Squibb Co. v. Superior Court of California

Bristol-Myers Squibb tightened the requirements for specific jurisdiction by holding that there must be an affiliation between the forum and the specific claims at issue. The case held that nonresident plaintiffs could not join their claims with resident plaintiffs' claims in a state court that lacked an adequate connection between the forum and the nonresidents' specific claims.

## Citation

582 U.S. 255 (2017)

## Year

2017

## Court

Supreme Court of the United States

## Facts

Over 600 plaintiffs from California and 33 other states filed suit against Bristol-Myers Squibb (BMS) in California state court, alleging that the blood-thinning drug Plavix had damaged their health. BMS was incorporated in Delaware and headquartered in New York. It maintained substantial operations in California, including a research facility, hundreds of employees, and significant sales revenue, but the nonresident plaintiffs did not obtain Plavix through California, were not prescribed the drug there, and did not suffer their injuries there.

## Procedural History

The California Superior Court denied BMS's motion to quash service on the nonresidents' claims. The California Court of Appeal reversed as to the nonresident plaintiffs. The California Supreme Court reversed again, applying a 'sliding scale' approach to specific jurisdiction. The U.S. Supreme Court granted certiorari.

## Issue

Whether a state court may exercise specific jurisdiction over a pharmaceutical company's claims brought by nonresident plaintiffs whose claims have no connection to the forum state, based on the company's general business contacts with the state and the similar claims of resident plaintiffs.

## Holding

The Supreme Court held that California courts lacked specific jurisdiction over BMS with respect to the nonresident plaintiffs' claims. Specific jurisdiction requires a connection between the forum and the specific claims at issue. The nonresidents' claims did not arise out of or relate to BMS's contacts with California, and the mere fact that other plaintiffs had similar California-based claims did not establish jurisdiction over the nonresidents' unrelated claims.

## Reasoning

Justice Alito's majority opinion rejected the California Supreme Court's sliding scale approach, under which the more extensive the defendant's forum contacts, the weaker the required connection between the claims and the forum. The Court held that specific jurisdiction requires a direct connection between the defendant's forum contacts and the plaintiff's particular claims. BMS's general research and sales activities in California did not give rise to the nonresidents' claims; those plaintiffs obtained and used Plavix in other states. The Court emphasized that allowing jurisdiction would make any large corporation subject to suit anywhere it does business, even for claims entirely unconnected to the forum.

## Dissent

Justice Sotomayor dissented, arguing that BMS's extensive activities in California, combined with its nationwide marketing of Plavix, created sufficient contacts for specific jurisdiction. She warned that the decision would impede the efficient resolution of mass tort litigation by preventing plaintiffs from consolidating their claims in a single forum.

## Impact

Bristol-Myers Squibb significantly affected mass tort litigation strategy by preventing nonresident plaintiffs from joining their claims with resident plaintiffs in state courts lacking a connection to the nonresidents' claims. The decision accelerated the movement of mass tort cases to federal multidistrict litigation (MDL) and raised unresolved questions about whether the same rule applies in federal court. The case reinforced the trend toward narrowing personal jurisdiction that began with Daimler.

## Key Quotes

- In order for a court to exercise specific jurisdiction over a claim, there must be an affiliation between the forum and the underlying controversy, principally, an activity or an occurrence that takes place in the forum State.
- What is needed—and what is missing here—is a connection between the forum and the specific claims at issue.
- The mere fact that other plaintiffs were prescribed, obtained, and ingested Plavix in California—and allegedly sustained the same injuries as did the nonresidents—does not allow the State to assert specific jurisdiction over the nonresidents' claims.

## Related Cases

- daimler-ag-v-bauman
- international-shoe-v-washington
- ford-motor-co-v-montana
- world-wide-volkswagen-v-woodson

## Exam Relevance

Bristol-Myers Squibb is frequently tested in civil procedure exams involving specific jurisdiction and mass tort litigation. Students may be asked to analyze whether a court has specific jurisdiction over claims brought by nonresident plaintiffs and to evaluate the impact on litigation strategy. The case also appears in questions about the distinction between general and specific jurisdiction.

## Study Tips

- Focus on the requirement that the plaintiff's specific claim must arise out of or relate to the defendant's contacts with the forum — general business contacts are insufficient for specific jurisdiction.
- Understand how Bristol-Myers Squibb relates to Daimler: together they limit both general and specific jurisdiction over large corporations.
- Consider the open question of whether Bristol-Myers Squibb applies in federal court, particularly in MDL proceedings.
- Be prepared to discuss the practical impact on mass tort litigation and why plaintiffs now increasingly file in federal court.

## Doctrine Established

Claim-Specific Connection Requirement for Specific Jurisdiction

---
Source: [Bristol-Myers Squibb Co. v. Superior Court of California — CaseBriefly](https://casebriefly.com/landmark-cases/bristol-myers-squibb-v-superior-court)
